FDA Grants Traditional Approval To Eisai's Leqembi To Treat Adult Patients With Alzheimer's Disease
7/7 03:24
(RTTNews) - The U.S. Food and Drug Administration granted a traditional approval to Eisai Co., Ltd. (ESALY.PK, ESALF.PK) and Biogen Inc.'s (BIIB) Leqembi (lecanemab-irmb) to treat adult patients with Alzheimer's Disease....